| Literature DB >> 29128158 |
Ahmed Lawan1, Anton M Bennett2.
Abstract
The mitogen-activated protein kinases (MAPKs) participate in a multitude of processes that control hepatic metabolism. The liver regulates glucose and lipid metabolism, and under pathophysiological conditions such as obesity, type 2 diabetes mellitus (T2DM), and non-alcoholic fatty liver disease (NAFLD) these processes become dysfunctional. Stress responses activate the hepatic MAPKs, and this is thought to impair insulin action and lipid metabolism. The MAPKs also activate the MAPK phosphatases (MKPs) which oppose their actions. How the MAPK/MKP balance is controlled in liver metabolism and how perturbations in these activities contribute to metabolic disease remains unclear. Discussion of recent insights into the MAPK/MKP signaling role in hepatic metabolic function and disease will be the focus of this review.Entities:
Keywords: liver; metabolism; mitogen-activated protein kinase; obesity; signal transduction; type 2 diabetes
Mesh:
Substances:
Year: 2017 PMID: 29128158 PMCID: PMC5774993 DOI: 10.1016/j.tem.2017.10.007
Source DB: PubMed Journal: Trends Endocrinol Metab ISSN: 1043-2760 Impact factor: 12.015